does midi health prescribe tirzepatide The FDA has approved oral Wegovy—a daily pill option for weight loss that uses semaglutide, the same active ingredient as injectable GLP-1s., As Midi’s Chief Medical Officer, Dr. Kathleen Jordan Tirzepatide Dosing - A Patient
Description
Have Multiple Endocrine Neoplasia syndrome type 2
GLP-1 receptor agonists like semaglutide (Ozempic, Wegovy) and tirzepatide (Zepbound, Mounjaro) have revolutionized weight management and diabetes care, offering significant benefits in blood sugar control, appetite suppression, and weight loss
Wegovy is a GLP-1 medication, or a glucagon-like peptide receptor agonist
Start for $49 with a full blood panel and provider consultation.
